Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems, FIND to Develop TB Diagnostics

NEW YORK, Feb. 1 (GenomeWeb News) - Australia-based Proteome Systems and the Foundation for Innovative Diagnostics of Geneva, Switzerland, will co-develop biomarkers for a tuberculosis diagnostic test, the company said yesterday.

According to the deal, FIND will provide clinical material and assistance as well as fast tracking in return for rights to distribute the reagent products to the public health sector in developing countries, said PXL.

Proteome Systems said the test will differ from available TB diagnostics because it will "directly detect proteins expressed by the TB causative microbe mycobacterium tuberculosis in infected individuals as well as [measure] the severity of an infection."

As Genome Web News reported last March, Proteome Systems, based in Sidney, received a $2-million grant from the Australian government for TB diagnostic development.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.